Blog

Welcome to the fourth edition of the Athena BDA Newsletter. Each month we bring you a summary of all the high priority FDA approvals, new indication approvals and flag pipeline blockbuster assets that have submission updates or positive phase 2/3 data announcements. We dedicate countless hours exploring the farthest corners of the internet to deliver a […]

Welcome to the third edition of the Athena BDA Newsletter. Each month we bring you a summary of all the high priority FDA approvals, new indication approvals and flag pipeline blockbuster assets that have submission updates or positive phase 2/3 data announcements. Each month we spend days trawling through the deepest recesses of the internet to […]